Showing results (601-610 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|January 25, 2013
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?Montarat Thavorncharoensap, Yot Teerawattananon, Sirin Natanant, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 18, 2013
Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime modelMatthew R Reynolds, Jonas Nilsson, Orjan Akerborg, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 19, 2012
The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit packageThunyarat Anothaisintawee, Pattara Leelahavarong, Tanapat Ratanapakorn, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 29, 2013
Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research DatabaseCatherine Reed, Jihyung Hong, Diego Novick, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 10, 2013
Epidemiology of falls and osteoporotic fractures: a systematic reviewAlan Morrison, Tao Fan, Shuvayu S Sen, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing modelHwa-Young Lee, Bong-Min Yang, Ji-Min Hong, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 25, 2013
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in SpainJosep Darbà, Nuria Pérez-Álvarez, Lisette Kaskens, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 10, 2013
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluationJaro Wex, Manpreet Sidhu, Isaac Odeyemi, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 10, 2013
Follow-up analysis of federal process of care data reported from three acute care hospitals in rural AppalachiaE Scott Sills, Liubomir Chiriac, Denis Vaughan, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 28, 2012
The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes ModelAndrew van Herick, C Andy Schuetz, Peter Alperin, et al.
Pageof 102